: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies."..
.
.
suven life sciences' pashamylaram facility successfully completes usfda inspection